SPOTLIGHT -
GNRH agonists vs antagonists in prostate cancer: How to choose
Many factors play into decision-making process when weighing agents.
GU oncologist's perspective: pandemic poses unique challenges in vulnerable patients
Patients with cancer are particularly susceptible to negative consequences of COVID-19.
